DOSSIER · 13F Holders · Q2 2026
EVAX
EVAXION BIOTECH A/S
20 institutions still hold EVAXION BIOTECH A/S as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 29970R303·20 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
20 institutions reported EVAX in Q2 2026. Merck & Co., Inc. leads at 76.5% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.